These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2110604)

  • 1. Predictive value of the single-breath nitrogen test for hospitalization due to respiratory disease.
    Vestbo J; Knudsen KM; Rasmussen FV
    Lung; 1990; 168(2):93-101. PubMed ID: 2110604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of COPD and Related Events Improves by Combining Spirometry and the Single Breath Nitrogen Test.
    Olofson J; Bake B; Bergman B; Ullman A; Svärdsudd K
    COPD; 2018 Oct; 15(5):424-431. PubMed ID: 30822242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The single-breath nitrogen test, mortality, and cancer.
    Vestbo J; Rasmussen FV
    Am Rev Respir Dis; 1990 Nov; 142(5):1022-5. PubMed ID: 2240822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The single breath nitrogen test and mortality--A 38 years follow up.
    Olofson J; Bake B; Bergman B; Svärdsudd K
    Respir Med; 2016 Mar; 112():75-80. PubMed ID: 26803380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single breath N2-test predicts the rate of decline in FEV1. The study of men born in 1913 and 1923.
    Olofsson J; Bake B; Svärdsudd K; Skoogh BE
    Eur J Respir Dis; 1986 Jul; 69(1):46-56. PubMed ID: 3743689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease.
    Vestbo J; Rasmussen FV
    Eur Respir J; 1989 Sep; 2(8):710-5. PubMed ID: 2806492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.
    Deus CAL; Vigário PS; Guimarães FS; Lopes AJ
    Braz J Med Biol Res; 2018; 51(4):e7059. PubMed ID: 29490001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.
    Vestbo J; Knudsen KM; Rasmussen FV
    Respir Med; 1989 May; 83(3):207-11. PubMed ID: 2595038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation?
    Buist AS; Vollmer WM; Johnson LR; McCamant LE
    Am Rev Respir Dis; 1988 Feb; 137(2):293-301. PubMed ID: 3341624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function.
    Detels R; Tashkin DP; Simmons MS; Carmichael HE; Sayre JW; Rokaw SN; Coulson AH
    Chest; 1982 Nov; 82(5):630-8. PubMed ID: 7128229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.
    Stănescu D; Sanna A; Veriter C; Robert A
    Chest; 1998 Aug; 114(2):416-25. PubMed ID: 9726724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does abnormal single-breath nitrogen wash-out predict an accelerated decline in FEV1 in lung-healthy subjects?
    Dahlqvist M
    Clin Physiol; 1995 Sep; 15(5):459-66. PubMed ID: 8846666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double tracer gas single-breath washout: reproducibility in healthy subjects and COPD.
    Husemann K; Berg N; Engel J; Port J; Joppek C; Tao Z; Singer F; Schulz H; Kohlhäufl M
    Eur Respir J; 2014 Nov; 44(5):1210-22. PubMed ID: 25102960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function changes in smokers with normal conventional spirometry.
    Marco M; Minette A
    Am Rev Respir Dis; 1976 Oct; 114(4):723-38. PubMed ID: 970748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.
    Chambers DC; Boldy DA; Ayres JG
    Respir Med; 1999 Oct; 93(10):726-33. PubMed ID: 10581662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older.
    Turkeshi E; Vaes B; Andreeva E; Matheï C; Adriaensen W; Van Pottelbergh G; Degryse JM
    BMC Geriatr; 2015 Feb; 15():15. PubMed ID: 25888051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD.
    Veljanovski J; Ouellette DR
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1061-1069. PubMed ID: 29681729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of smokers and nonsmokers. 5-6 year follow-up using spirometry and the single breath N2 test.
    Buist S; Nagy J
    Chest; 1980 Feb; 77(2 Suppl):259. PubMed ID: 7357899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.